Section
Genetics, therapies, and biomedical tools, reported with limits and stage in plain view.
RSS for this section
Genetics & Medicine
In a randomized phase 3 trial of 1,137 patients with resected high-risk melanoma, adding an individualized neoantigen mRNA therapy to pembrolizumab improved recurrence-free and distant-metastasis-free survival.
20 November 2026 · Next Epoch News